These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 37125735

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Intra- and inter- individual rivaroxaban concentrations and potential bleeding risk in patients with atrial fibrillation.
    Miklič M, Mavri A, Vene N, Söderblom L, Božič-Mijovski M, Pohanka A, Antovic J, Malmström RE.
    Eur J Clin Pharmacol; 2019 Aug; 75(8):1069-1075. PubMed ID: 31139866
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Clinical evaluation of laboratory methods to monitor exposure of rivaroxaban at trough and peak in patients with atrial fibrillation.
    Al-Aieshy F, Malmström RE, Antovic J, Pohanka A, Rönquist-Nii Y, Berndtsson M, Al-Khalili F, Skeppholm M.
    Eur J Clin Pharmacol; 2016 Jun; 72(6):671-9. PubMed ID: 27066956
    [Abstract] [Full Text] [Related]

  • 6. Comparison of calibrated chromogenic anti-Xa assay and PT tests with LC-MS/MS for the therapeutic monitoring of patients treated with rivaroxaban.
    Douxfils J, Tamigniau A, Chatelain B, Chatelain C, Wallemacq P, Dogné JM, Mullier F.
    Thromb Haemost; 2013 Oct; 110(4):723-31. PubMed ID: 23846172
    [Abstract] [Full Text] [Related]

  • 7. Comparison of the effect of the anti-Xa direct oral anticoagulants apixaban, edoxaban, and rivaroxaban on coagulation assays.
    Gosselin R, Grant RP, Adcock DM.
    Int J Lab Hematol; 2016 Oct; 38(5):505-13. PubMed ID: 27265752
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Laboratory monitoring of rivaroxaban and assessment of its bleeding risk.
    Zhang Y, Qian Q, Qian G, Sun G.
    Br J Biomed Sci; 2016 Jul; 73(3):134-139. PubMed ID: 27400196
    [Abstract] [Full Text] [Related]

  • 11. Multianalyte Determination of NOACs Using LC-MS/MS and Comparison with Functional Coagulation Assays.
    Slavik L, Lukes J, Friedecky D, Zhanelova M, Nemcova M, Ulehlova J, Prochazkova J, Hlusi A, Palova M, Vaclavik J.
    Clin Lab; 2018 Oct 01; 64(10):1611-1621. PubMed ID: 30336535
    [Abstract] [Full Text] [Related]

  • 12. Poor comparability of coagulation screening test with specific measurement in patients receiving direct oral anticoagulants: results from a multicenter/multiplatform study.
    Testa S, Legnani C, Tripodi A, Paoletti O, Pengo V, Abbate R, Bassi L, Carraro P, Cini M, Paniccia R, Poli D, Palareti G.
    J Thromb Haemost; 2016 Nov 01; 14(11):2194-2201. PubMed ID: 27566988
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Factor Xa inhibition by rivaroxaban in the trough steady state can significantly reduce thrombin generation.
    Horinaka S, Sugawara R, Yonezawa Y, Ishimitsu T.
    Br J Clin Pharmacol; 2018 Jan 01; 84(1):79-87. PubMed ID: 28888219
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Evaluation of point-of-care coagulation tests as alternatives to anti-Xa activity for monitoring the anticoagulant effects of rivaroxaban in healthy dogs.
    Lynch AM, Ruterbories LK, Griffith EH, Hanel RM, Stablein AP, Brooks MB.
    J Vet Emerg Crit Care (San Antonio); 2021 Jan 01; 31(1):18-24. PubMed ID: 33118685
    [Abstract] [Full Text] [Related]

  • 18. Accuracy and consistency of anti-Xa activity measurement for determination of rivaroxaban plasma levels.
    Studt JD, Alberio L, Angelillo-Scherrer A, Asmis LM, Fontana P, Korte W, Mendez A, Schmid P, Stricker H, Tsakiris DA, Wuillemin WA, Nagler M.
    J Thromb Haemost; 2017 Aug 01; 15(8):1576-1583. PubMed ID: 28574652
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Using a low-molecular weight heparin-calibrated anti-factor Xa assay to assess the concentration of apixaban and rivaroxaban.
    von Horn H, Rasmusson A, Söderblom L, Malmström RE, Antovic J.
    Int J Lab Hematol; 2022 Feb 01; 44(1):163-167. PubMed ID: 34523813
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.